EuroscreenFast maintains its activities despite Covid-19
EuroscreenFast maintains activities despite Covid-19
What's up ?
Latest news
News listing
New Publication in British Journal of Pharmacology
EuroscreenFast work published in British Journal of Pharmacology
EuroscreenFast activities transferred to EPICS Therapeutics SA
EPICS Therapeutics SA acquires Ogeda former assets, including the EuroscreenFast Business Unit which will continue to provide the same high-quality GPCR screening and assay development services
EuroscreenFast launches its new website
The talented people at Dogstudio designed a new visual identity and website for Euroscreen-Fast.
July 2018 Catalogue update
July 2018 assay catalogue updated including 50 new assays
Come and meet us at BIO Boston 2018
We'll be present at the BIO-International convenation in Boston on June 4-7, we'd loev to see you there!
Come and meet us at BIO-Europe Spring 2018
We'll be present at the BIO-Europe Spring meeting taking place in Amsterdam on March 12-14. If you plan to attend, it would be a great opportunity to meet!
EuroscreenFast obtient le renouvellement de son agrément Crédit Impôt Recherche (CIR)
Euroscreen announces name change to Ogeda
EuroscreenFast collaborates with Novartis on successful GPR15 deorphanization
Receptor internalization assays
